_News and insights from our companies and the experts in the field
Stay up to date with relevant news from the health and biotech fields. We will be sharing the latest updates from our portfolio companies but also exciting podcasts, interviews, reports and articles that will help broaden your horizon and understanding of the life sciences sector.

Immunitas Therapeutics announces a $478 Million global licensing agreement with Boehringer Ingelheim
May 12, 2026

April 16, 2026

April 7, 2026

March 18, 2026
No results found.